« Previous Next » Journal of Pediatric Urology
Volume 2, Issue 5 , Pages 399-401 , October 2006

Hazard of botulinum toxin type A injection into the detrusor in patients with an artificial urinary sphincter

Luca Mazzone
- Department of Paediatric Surgery, Kinderspital Universität Zürich, Kinderchirurgie, Steinwiesstrasse 75, 8032 Zürich, Switzerland
Daniel Weber
- Department of Paediatric Surgery, Kinderspital Universität Zürich, Kinderchirurgie, Steinwiesstrasse 75, 8032 Zürich, Switzerland
Marianne van der Hoeff
- Department of Radiology, Kinderspital Universität Zürich, Kinderchirurgie, Steinwiesstrasse 75, 8032 Zürich, Switzerland
Rita Gobet
- Department of Paediatric Surgery, Kinderspital Universität Zürich, Kinderchirurgie, Steinwiesstrasse 75, 8032 Zürich, Switzerland
Ricardo González
- Department of Paediatric Surgery, Kinderspital Universität Zürich, Kinderchirurgie, Steinwiesstrasse 75, 8032 Zürich, Switzerland
- Corresponding author. Tel.: +41 1 266 7111; fax: +41 1 266 8140.

Received 22 June 2006 ,Accepted 23 June 2006.

References

González R, Jednak R, Franc-Guimond J, Schimke CM. Treating neuropathic incontinence in children with seromuscular colocystoplasty and an artificial urinary sphincter. BJU Int. 2002;90:909–911
- MEDLINE
- CrossRef
Riccabona M, Koen M, Schindler M, Goedele B, Pycha A, Lusuardi L, et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol. 2004;171:845–848
Altaweel W, Jednack R, Bilodeau C, Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol. 2006;175:1102–1105
Schulte-Baukloh H, Knispel HH, Stolze T, Weiss C, Michael T, Miller K. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology. 2005;66:865–870